Biomark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
November 28, 2023 at 08:35 am EST
Biomark Diagnostics Inc. reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was CAD 0.042126 million compared to CAD 0.040957 million a year ago. Net loss was CAD 0.210463 million compared to CAD 0.527884 million a year ago.
For the six months, sales was CAD 0.081872 million compared to CAD 0.076857 million a year ago. Net loss was CAD 0.629318 million compared to CAD 0.947025 million a year ago.